1.Intra-Aneurysmal Glue Embolisation of a Giant Pulmonary Artery Pseudoaneurysm after Left Upper Lobe Lobectomy: Case Report.
Ashwin GARG ; Kiruthika CHANDRASEKARAN ; Sidram JADHAV ; Gurbaag CHANDOK ; Aparna RINGE ; Ashwini SANKHE
Korean Journal of Radiology 2013;14(3):455-459
We report a case of pseudoaneurysm of the anterior ascending branch of the left pulmonary artery, following a left upper lobectomy for pulmonary aspergillosis, for which we have done an endovascular treatment. This is the first case where complete pseudoaneurysm occlusion was accomplished after a transcatheter intra-aneurysmal N-butyl 2-cyanoacrylate (glue) injection.
Adult
;
Aneurysm, False/etiology/*therapy
;
Embolization, Therapeutic/adverse effects/*methods
;
Enbucrilate/*therapeutic use
;
Female
;
Humans
;
Pneumonectomy/adverse effects
;
Postoperative Complications/*therapy
;
*Pulmonary Artery
;
Pulmonary Aspergillosis/surgery
2.Single Lung Transplantation in Pulmonary Fibrosis Patients.
Hae Kyoon KIM ; Doo Yun LEE ; Hoe Chae PAIK ; Dong Suk MUN ; Ki Man BAE ; Jae Youl HAN ; Bum Koo CHO
The Journal of the Korean Society for Transplantation 1999;13(1):165-170
A lung transplantation in the case of idiopathic pulmonary fibrosis was performed on July 7th, 1996 by the department of Thoracic Surgery, Yonsei University Medical College. The 52 year-old male patient (having a past history of cholecystectomy, 6 years ago) suffering from severe dyspnea, progressively aggravating for last five years. On physical examinations, two surgical scars were found in his left chest wall and upper abdominal area and wheezing was auscultated in both lung fields. The pulmonary function test performed in march, 1996, revealed FVC of 1940 ml (51%) and FEV1 of 1680 ml/min (58%) and the arterial blood gas study showed pH 7.4 PaO2 43.2 mmHg, PaCO2 35.0 mmHg (room air), pH 7.4 PaO2 89.8 mmHg, PaCO2 40.8 mmHg (mask 5l/min). Through the coronary angiography, moderate degree of pulmonary hypertension and 50% stenosis of left anterior descending branch of his coronary arteries were detected. The right lung from 17 year old male under brain death was removed through a median sternotomy incision and immersed in 70 ml/Kg of preservation solution (modified Euro-collins). Preparing the recipient, the pulmonary artery was dissected and temporally ligated for 15minutes, after then, an arterial blood gas study was taken to reveal pH 6.97, PaO2 221 mmHg, PaCO2 126 mmHg (FiO2 1.0 PEEP 5 cm) and his pulmonary arterial pressure was 85/26 mmHg (when the systemic arterial pressure was 140/80 mmHg) that indicates the necessity of the cardiopulmonary bypass; extracorporeal circulation was initiated through the femoral artery and right atrium. Placing the donor lung in the ipsilateral thoracic cavity of the recipient, the bronchus was first anastomosed in an telescopic fashion (the smaller bronchus into the lumen of the larger one) using the prolene 4-0. The pulmonary artery was anastomosed by prolene 5-0 and the LA by prolene 4-0. The total ischemic time was 70 minutes and the bypass time was 145 minutes. For the postoperative immunosuppression, cyclosporin and immuran was used and 2 weeks of induction therapy with OKT3 was followed by steroid. No evidence of rejection was shown in the transbronchial lung biopsy, performed a week after the transplantation. Fever developed 3 month after and aspergillosis and CMV infection was suspected through the transbronchial lung biopsy; vigorous treatment was followed but the patient had expired after 82 days postoperative survival.
Adolescent
;
Arterial Pressure
;
Aspergillosis
;
Azathioprine
;
Biopsy
;
Brain Death
;
Bronchi
;
Cardiopulmonary Bypass
;
Cholecystectomy
;
Cicatrix
;
Constriction, Pathologic
;
Coronary Angiography
;
Coronary Vessels
;
Cyclosporine
;
Dyspnea
;
Extracorporeal Circulation
;
Femoral Artery
;
Fever
;
Heart Atria
;
Humans
;
Hydrogen-Ion Concentration
;
Hypertension, Pulmonary
;
Idiopathic Pulmonary Fibrosis
;
Immunosuppression
;
Lung Transplantation*
;
Lung*
;
Male
;
Middle Aged
;
Muromonab-CD3
;
Physical Examination
;
Polypropylenes
;
Pulmonary Artery
;
Pulmonary Fibrosis*
;
Respiratory Function Tests
;
Respiratory Sounds
;
Sternotomy
;
Thoracic Cavity
;
Thoracic Surgery
;
Thoracic Wall
;
Tissue Donors
3.Surgery for Pulmonary Fungal Infections Complicating Hematological Malignancies.
Takashi YAMAMICHI ; Hirotoshi HORIO ; Ayaka ASAKAWA ; Masayuki OKUI ; Masahiko HARADA
The Korean Journal of Thoracic and Cardiovascular Surgery 2018;51(5):350-355
BACKGROUND: The complication rate of fungal disease is higher among patients with hematological malignancies. We investigated the clinicobacteriological outcomes of resected pulmonary fungal infections complicating hematological malignancies. METHODS: Between 2001 and 2017, 21 patients with pulmonary fungal infections complicating hematological malignancies underwent resection, and their clinical records and survival were retrospectively reviewed. RESULTS: The median age of the patients was 47 years, and 13 were male. The histological diagnoses were pulmonary aspergillosis (19 cases), mucormycosis (1 case), and cryptococcosis (1 case). The indications for surgery were resistance to antifungal therapy and the necessity of surgery before hematopoietic stem cell transplantation in 13 and 8 cases, respectively. The diagnoses of the hematological malignancies were acute myelogenous leukemia (10 cases), acute lymphocytic leukemia (5 cases), myelodysplastic syndrome (3 cases), and chronic myelogenous leukemia, malignant lymphoma, and extramedullary plasmacytoma (1 case each). The surgical procedures were partial resection (11 cases), segmentectomy (5 cases), lobectomy (4 cases), and cavernostomy (1 case). The size of the lesions was 0.9–8.5 cm. Fourteen cases had cavitation. There were no surgical-related deaths or fungal progression. CONCLUSION: Pulmonary fungal infections are resistant to treatments for hematological malignancies. Since the treatment of the underlying disease is extended and these infections often recur and are exacerbated, surgery should be considered when possible.
Cryptococcosis
;
Diagnosis
;
Hematologic Neoplasms*
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
Leukemia, Myeloid, Acute
;
Lung Diseases, Fungal*
;
Lymphoma
;
Male
;
Mastectomy, Segmental
;
Mucormycosis
;
Mycoses
;
Myelodysplastic Syndromes
;
Plasmacytoma
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
Pulmonary Aspergillosis
;
Retrospective Studies
;
Thoracic Surgery